Details for 2013867921
Up to date per 04.04.2026
Actions
Details for 2013867921
Granted/Registered
European Patent
04.11.2015 A
21.02.2018 B1
28.12.2012
KR
20120157583
A61K 38/09 20060101AFI20170719BHEP
Owner
Chong Kun Dang Pharmaceutical Corp.8 Chungjeong-ro Seodaemun-gu Seoul 120-756KR
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
YOON, Sang Phil315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
KO, Ki Seong315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
YU, Ha Na315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
BAIK, Hye Jung315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
YANG, Won Kyu315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
KO, Jin Young315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
PARK, So Hyun315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
JUNG, Sung Bum315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
AN, Sung Won315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
KI, Min Hyo315-20 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi-do 446-916KR
Information about Fees